학술논문

1298P PD-1 inhibitors combined with chemotherapy may preferentially improve survival in metastatic NSCLC with myeloid-mediated primary resistance to immunotherapy
Document Type
Abstract
Source
In Annals of Oncology September 2021 32 Supplement 5:S1005-S1006
Subject
Language
ISSN
0923-7534